BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

94.125 -

+1.105 (+1.19%)
Range 92.500 - 95.990   (3.77%)
Open 93.380
Previous Close 93.020
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 1,035,633
Value 82,241,636
Remark -
Delayed prices. Updated at 09 May 2026 08:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis